Source: Business Wire

Press Release: Jubilant Pharmova : Global Lyme Disease Clinical Trials Review, H2, 2016 - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Lyme Disease Global Clinical Trials Review, H2, 2016" clinical trials to their offering. This report provides top line data relating to the clinical trials on Lyme Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status

Read full article »

Top Competitors or Alternatives

Looks like nobody has added any competitors for Jubilant Pharmova yet.

Missing a competitor? Contribute!

Annual Revenue
$900.3M
Employees
36
CEO Avatar

CEO

- -

CEO Approval Rating

- -/100